Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of GBP 6.84 million. The enterprise value is -7.48 million.

Market Cap	6.84M
Enterprise Value	-7.48M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	33.71M
Shares Outstanding	n/a
Shares Change (YoY)	+4.93%
Shares Change (QoQ)	+3.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	31.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.53
PB Ratio	0.18
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.27
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.32

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.04.

Current Ratio	4.43
Quick Ratio	4.02
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.80% and return on invested capital (ROIC) is -36.62%.

Return on Equity (ROE)	-56.80%
Return on Assets (ROA)	-33.82%
Return on Invested Capital (ROIC)	-36.62%
Return on Capital Employed (ROCE)	-77.10%
Revenue Per Employee	20,508
Profits Per Employee	-210,269
Employee Count	132
Asset Turnover	0.05
Inventory Turnover	0.60

Taxes

In the past 12 months, Co-Diagnostics has paid 36,074 in taxes.

Income Tax	36,074
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-78.03%
50-Day Moving Average	0.30
200-Day Moving Average	0.71
Relative Strength Index (RSI)	48.56
Average Volume (20 Days)	6,029

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.73

Income Statement

In the last 12 months, Co-Diagnostics had revenue of GBP 2.71 million and -27.76 million in losses. Loss per share was -0.90.

Revenue	2.71M
Gross Profit	2.10M
Operating Income	-29.70M
Pretax Income	-27.72M
Net Income	-27.76M
EBITDA	-28.67M
EBIT	-29.70M
Loss Per Share	-0.90

Full Income Statement

Balance Sheet

The company has 16.62 million in cash and 1.49 million in debt, giving a net cash position of 15.13 million.

Cash & Cash Equivalents	16.62M
Total Debt	1.49M
Net Cash	15.13M
Net Cash Per Share	n/a
Equity (Book Value)	37.09M
Book Value Per Share	1.10
Working Capital	14.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.76 million and capital expenditures -338,986, giving a free cash flow of -23.10 million.

Operating Cash Flow	-22.76M
Capital Expenditures	-338,986
Free Cash Flow	-23.10M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	77.52%
Operating Margin	-1,097.15%
Pretax Margin	-1,023.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.93%
Shareholder Yield	n/a
Earnings Yield	-405.88%
FCF Yield	-337.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Co-Diagnostics has an Altman Z-Score of -0.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.09
Piotroski F-Score	2